• Consensus Rating: Hold
  • Consensus Price Target: $301.67
  • Forecasted Upside: -24.98 %
  • Number of Analysts: 10
  • Breakdown:
  • 1 Sell Ratings
  • 7 Hold Ratings
  • 2 Buy Ratings
  • 0 Strong Buy Ratings
$402.11
▲ +6.53 (1.65%)

This chart shows the closing price for WAT by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Waters Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for WAT and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for WAT

Analyst Price Target is $301.67
▼ -24.98% Downside Potential
This price target is based on 10 analysts offering 12 month price targets for Waters in the last 3 months. The average price target is $301.67, with a high forecast of $400.00 and a low forecast of $185.00. The average price target represents a -24.98% upside from the last price of $402.11.

This chart shows the closing price for WAT for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart

Current Consensus is Hold

The current consensus among 10 investment analysts is to hold stock in Waters. This Hold consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 1 buy ratings
  • 5 hold ratings
  • 5 sell ratings
4/1/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 5 hold ratings
  • 4 sell ratings
6/30/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 6 hold ratings
  • 4 sell ratings
9/28/2020
  • 0 strong buy ratings
  • 1 buy ratings
  • 8 hold ratings
  • 4 sell ratings
12/27/2020
  • 0 strong buy ratings
  • 1 buy ratings
  • 8 hold ratings
  • 3 sell ratings
3/27/2021
  • 0 strong buy ratings
  • 1 buy ratings
  • 7 hold ratings
  • 2 sell ratings
6/25/2021
  • 0 strong buy ratings
  • 2 buy ratings
  • 7 hold ratings
  • 1 sell ratings
8/24/2021
  • 0 strong buy ratings
  • 2 buy ratings
  • 7 hold ratings
  • 1 sell ratings
9/23/2021

Latest Recommendations

  • 0 strong buy ratings
  • 2 buy ratings
  • 7 hold ratings
  • 1 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
8/4/2021SVB LeerinkBoost Price TargetMarket Perform$370.00 ➝ $385.00Medium
8/4/2021Robert W. BairdBoost Price TargetNeutral$297.00 ➝ $360.00Medium
8/4/2021CitigroupBoost Price TargetNeutral$315.00 ➝ $400.00Medium
7/6/2021Evercore ISIUpgradeIn-Line ➝ Outperform$400.00Medium
5/6/2021SVB LeerinkBoost Price TargetMarket Perform$290.00 ➝ $300.00Low
5/6/2021Wells Fargo & CompanyBoost Price TargetUnderweight$280.00 ➝ $290.00Low
2/3/2021CitigroupBoost Price Target$250.00 ➝ $300.00Low
1/7/2021Wells Fargo & CompanyDowngradeEqual Weight ➝ Underweight$235.00N/A
12/17/2020Cleveland ResearchUpgradeUnderperform ➝ BuyLow
12/16/2020Smith Barney CitigroupUpgradeSell ➝ NeutralLow
12/2/2020The Goldman Sachs GroupInitiated CoverageNeutral$230.00Low
11/9/2020KeyCorpInitiated CoverageSector Weight ➝ Sector Weight$235.00Medium
10/28/2020Stifel NicolausBoost Price TargetHold$220.00 ➝ $230.00Medium
10/28/2020Smith Barney CitigroupBoost Price Target$180.00 ➝ $185.00Low
10/28/2020Wells Fargo & CompanyBoost Price TargetEqual Weight$230.00 ➝ $235.00Low
10/28/2020SVB LeerinkBoost Price TargetMarket Perform$225.00 ➝ $230.00Low
7/29/2020Stifel NicolausBoost Price TargetHold$180.00 ➝ $220.00High
7/29/2020SVB LeerinkBoost Price TargetMarket Perform$195.00 ➝ $225.00High
7/29/2020CitigroupBoost Price TargetSell$150.00 ➝ $180.00High
7/28/2020Needham & Company LLCInitiated CoverageSellHigh
7/28/2020JPMorgan Chase & Co.UpgradeUnderweight ➝ NeutralLow
7/16/2020Wells Fargo & CompanyUpgradeUnderweight ➝ Equal Weight$175.00 ➝ $225.00Medium
4/29/2020Bank of AmericaLower Price TargetUnderperform$160.00 ➝ $145.00High
4/29/2020Stifel NicolausBoost Price TargetHold$176.00 ➝ $180.00Medium
4/29/2020SVB LeerinkLower Price TargetMarket Perform$210.00 ➝ $195.00High
4/28/2020Needham & Company LLCInitiated CoverageSellHigh
4/28/2020UBS GroupLower Price TargetNeutral$223.00 ➝ $212.00Low
4/2/2020Stifel NicolausLower Price TargetHold$210.00 ➝ $176.00Low
3/30/2020Wells Fargo & CompanyLower Price TargetUnderweight$210.00 ➝ $180.00Medium
3/26/2020BarclaysLower Price TargetUnderweight$186.00 ➝ $172.00High
3/20/2020CitigroupLower Price TargetSell$190.00 ➝ $150.00Medium
2/4/2020Needham & Company LLCReiterated RatingSellHigh
1/8/2020Needham & Company LLCDowngradeHold ➝ UnderperformMedium
1/7/2020Wells Fargo & CompanyInitiated CoverageUnderweight$215.00High
1/6/2020CitigroupInitiated CoverageSell$190.00Medium
1/3/2020Needham & Company LLCInitiated CoverageHold$177.00Medium
1/3/2020Bank of AmericaUpgradeUnderperform ➝ NeutralMedium
12/4/2019BTIG ResearchDowngradeBuy ➝ NeutralLow
11/14/2019Stifel NicolausInitiated CoverageHold$210.00Medium
10/29/2019Needham & Company LLCReiterated RatingHoldHigh
10/9/2019BarclaysDowngradeEqual Weight ➝ Underweight$210.00 ➝ $195.00Low
7/16/2019Bank of AmericaDowngradeNeutral ➝ UnderperformLow
6/12/2019Cleveland ResearchDowngradeNeutral ➝ UnderperformMedium
5/30/2019Wolfe ResearchInitiated CoverageUnderperform ➝ UnderperformLow
4/24/2019UBS GroupLower Price TargetNeutral ➝ Neutral$248.00 ➝ $230.00Low
4/24/2019Robert W. BairdLower Price TargetNeutral ➝ Neutral$211.00 ➝ $209.00Low
4/24/2019BarclaysLower Price TargetEqual Weight ➝ Equal Weight$218.00 ➝ $210.00Low
1/25/2019BarclaysReiterated RatingHold$200.00Medium
1/24/2019BTIG ResearchBoost Price TargetBuy$260.00Medium
1/24/2019Robert W. BairdDowngradeOutperform ➝ Neutral$191.00 ➝ $211.00Medium
1/3/2019Bank of AmericaUpgradeUnderperform ➝ NeutralHigh
1/2/2019Needham & Company LLCInitiated CoverageHold ➝ Hold$177.00High
12/12/2018JPMorgan Chase & Co.DowngradeNeutral ➝ Underweight$185.00 ➝ $180.00Low
12/9/2018The Goldman Sachs GroupDowngradeNeutral ➝ Sell$200.83Low
11/30/2018The Goldman Sachs GroupDowngradeNeutral ➝ Sell$185.00 ➝ $180.00Medium
10/24/2018UBS GroupLower Price TargetNeutral ➝ Neutral$210.00 ➝ $200.00High
10/24/2018BarclaysLower Price TargetEqual Weight ➝ Equal Weight$200.00 ➝ $190.00High
10/24/2018JPMorgan Chase & Co.Lower Price TargetNeutral ➝ Neutral$200.00 ➝ $185.00High
10/11/2018Cleveland ResearchUpgradeSell ➝ NeutralHigh
10/10/2018Morgan StanleyBoost Price TargetEqual Weight ➝ Equal Weight$204.00 ➝ $211.00Medium
10/9/2018UBS GroupInitiated CoverageNeutral ➝ Neutral$210.00Low
10/8/2018SVB LeerinkDowngradeOutperform ➝ Market PerformHigh
7/25/2018Robert W. BairdBoost Price TargetOutperform ➝ Outperform$201.00 ➝ $212.00Medium
7/25/2018Morgan StanleyLower Price TargetEqual Weight ➝ Equal Weight$205.00 ➝ $204.00Low
7/17/2018Janney Montgomery ScottDowngradeBuy ➝ Neutral$230.00 ➝ $211.00Medium
7/16/2018Bank of AmericaDowngradeNeutral ➝ Underperform$190.00Medium
7/13/2018Morgan StanleyBoost Price TargetEqual Weight$200.00 ➝ $205.00High
6/14/2018Cleveland ResearchDowngradeNeutral ➝ UnderperformMedium
4/25/2018BarclaysLower Price TargetEqual Weight ➝ Equal Weight$208.00 ➝ $200.00Medium
4/25/2018Morgan StanleyLower Price TargetEqual Weight ➝ Equal Weight$218.00 ➝ $200.00Low
4/25/2018Robert W. BairdLower Price TargetOutperform ➝ Outperform$220.00 ➝ $201.00Low
4/25/2018Jefferies Financial GroupReiterated RatingHold$200.00Medium
4/25/2018SVB LeerinkSet Price TargetBuy$230.00 ➝ $214.00Medium
4/25/2018CowenReiterated RatingHold$215.00Medium
4/11/2018Morgan StanleyLower Price TargetEqual Weight ➝ Equal Weight$237.00 ➝ $218.00Low
1/25/2018BTIG ResearchReiterated RatingBuyLow
1/24/2018BarclaysBoost Price TargetEqual Weight ➝ Equal Weight$202.00 ➝ $208.00N/A
1/24/2018Janney Montgomery ScottBoost Price TargetBuy ➝ Buy$200.00 ➝ $230.00N/A
1/24/2018JPMorgan Chase & Co.Boost Price TargetNeutral ➝ Neutral$180.00 ➝ $200.00N/A
1/24/2018Robert W. BairdBoost Price TargetOutperform ➝ Outperform$219.00 ➝ $220.00N/A
1/24/2018CitigroupBoost Price TargetNeutral ➝ Neutral$190.00 ➝ $223.00N/A
1/23/2018William BlairReiterated RatingOutperformLow
1/8/2018BarclaysReiterated RatingHold$202.00Medium
1/5/2018BTIG ResearchInitiated CoverageBuy ➝ Buy$230.00Medium
1/3/2018Evercore ISIInitiated CoverageIn-Line$198.00Medium
12/4/2017Morgan StanleyUpgradeUnderweight ➝ Equal Weight$192.00High
11/10/2017Bank of AmericaBoost Price TargetNeutral$192.00 ➝ $202.00N/A
11/3/2017CowenReiterated RatingHold$190.00N/A
10/25/2017CitigroupReiterated RatingNeutral$180.00N/A
10/25/2017BarclaysBoost Price TargetEqual Weight$188.00 ➝ $193.00N/A
10/25/2017Deutsche Bank AktiengesellschaftBoost Price TargetHold$199.00 ➝ $200.00N/A
10/25/2017Robert W. BairdBoost Price TargetOutperform$196.00 ➝ $199.00N/A
10/9/2017Cleveland ResearchDowngradeBuy ➝ NeutralN/A
10/6/2017Morgan StanleyReiterated RatingUnderweight ➝ Underweight$183.00 ➝ $192.00N/A
9/26/2017The Goldman Sachs GroupInitiated CoverageHold$180.00Low
8/31/2017Jefferies Financial GroupReiterated RatingHold$175.00Low
7/27/2017Jefferies Financial GroupReiterated RatingHold$175.00Low
7/26/2017Morgan StanleyReiterated RatingUnderweight$174.00 ➝ $183.00Low
7/21/2017Bank of AmericaReiterated RatingNeutral$180.00 ➝ $192.00Low
7/14/2017CowenReiterated RatingHold$190.00Medium
7/14/2017Jefferies Financial GroupReiterated RatingHold$170.00Low
7/13/2017Wells Fargo & CompanyReiterated RatingOutperform$195.00 ➝ $205.00Low
7/10/2017Deutsche Bank AktiengesellschaftDowngradeBuy ➝ Hold$183.00 ➝ $194.00High
5/1/2017Janney Montgomery ScottUpgradeNeutral ➝ Buy$185.00 ➝ $200.00Medium
4/29/2017Deutsche Bank AktiengesellschaftReiterated RatingBuy$166.00 ➝ $183.00Medium
4/26/2017BarclaysSet Price TargetHold$160.00Low
4/26/2017CowenBoost Price TargetMarket Perform$160.00 ➝ $175.00Low
4/25/2017Cantor FitzgeraldReiterated RatingBuy$170.00 ➝ $190.00Low
3/3/2017Evercore ISIDowngradeHold ➝ UnderperformN/A
3/3/2017Jefferies Financial GroupBoost Price TargetHold$147.00 ➝ $150.00N/A
3/3/2017Cantor FitzgeraldReiterated RatingOverweight$170.00N/A
1/24/2017Cantor FitzgeraldSet Price TargetBuy$170.00N/A
1/18/2017Deutsche Bank AktiengesellschaftReiterated RatingBuy$160.00N/A
1/9/2017BarclaysReiterated RatingHold$148.00N/A
1/6/2017William BlairUpgradeMarket Perform ➝ OutperformN/A
12/8/2016Cantor FitzgeraldSet Price TargetBuy$170.00N/A
11/10/2016SVB LeerinkReiterated RatingOutperform$163.00N/A
10/28/2016Jefferies Financial GroupReiterated RatingHold$150.00 ➝ $145.00N/A
10/25/2016Cantor FitzgeraldReiterated RatingBuy$170.00N/A
(Data available from 9/24/2016 forward)

News Sentiment Rating

0.13 (Hold)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 8 very positive mentions
  • 32 positive mentions
  • 7 negative mentions
  • 8 very negative mentions
2/26/2021
  • 0 very positive mentions
  • 15 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
3/28/2021
  • 0 very positive mentions
  • 5 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
4/27/2021
  • 0 very positive mentions
  • 14 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
5/27/2021
  • 0 very positive mentions
  • 10 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
6/26/2021
  • 3 very positive mentions
  • 22 positive mentions
  • 13 negative mentions
  • 11 very negative mentions
7/26/2021
  • 10 very positive mentions
  • 40 positive mentions
  • 13 negative mentions
  • 6 very negative mentions
8/25/2021
  • 5 very positive mentions
  • 41 positive mentions
  • 9 negative mentions
  • 4 very negative mentions
9/24/2021

Current Sentiment

  • 5 very positive mentions
  • 41 positive mentions
  • 9 negative mentions
  • 4 very negative mentions

Recent Stories by Sentiment

Waters logo
Waters Corp. is a specialty measurement company which engages in analytical workflow solutions involving liquid chromatography, mass spectrometry and thermal analysis innovations. It operates through the Waters and TA segments. The Waters segment consists of liquid chromatography instruments, mass spectrometry, and precision chemistry consumable products and related services. The TA segment products and services include thermal analysis, rheometry and calorimetry instrument systems, and service sales. The company was founded by James Logan Waters in 1958 and is headquartered in Milford, MA.
Read More

Today's Range

Now: $402.11
Low: $398.12
High: $405.06

50 Day Range

MA: $399.63
Low: $362.99
High: $424.70

52 Week Range

Now: $402.11
Low: $187.31
High: $428.22

Volume

416,087 shs

Average Volume

372,599 shs

Market Capitalization

$24.67 billion

P/E Ratio

38.01

Dividend Yield

N/A

Beta

0.8

Frequently Asked Questions

What sell-side analysts currently cover shares of Waters?

The following Wall Street sell-side analysts have issued stock ratings on Waters in the last twelve months: Citigroup Inc., Cleveland Research, Evercore ISI, KeyCorp, Robert W. Baird, Smith Barney Citigroup, Stifel Nicolaus, SVB Leerink LLC, The Goldman Sachs Group, Inc., TheStreet, Wells Fargo & Company, and Zacks Investment Research.
View the latest analyst ratings for WAT.

What is the current price target for Waters?

9 Wall Street analysts have set twelve-month price targets for Waters in the last year. Their average twelve-month price target is $301.67, suggesting a possible downside of 25.0%. Evercore ISI has the highest price target set, predicting WAT will reach $400.00 in the next twelve months. Smith Barney Citigroup has the lowest price target set, forecasting a price of $185.00 for Waters in the next year.
View the latest price targets for WAT.

What is the current consensus analyst rating for Waters?

Waters currently has 1 sell rating, 7 hold ratings and 2 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Hold." A "hold" rating indicates that analysts believe investors should keep any existing positions they have in WAT, but not buy more shares or sell existing shares.
View the latest ratings for WAT.

How do I contact Waters' investor relations team?

Waters' physical mailing address is 34 MAPLE STREET, MILFORD MA, 01757. The medical instruments supplier's listed phone number is (508) 478-2000 and its investor relations email address is [email protected] The official website for Waters is www.waters.com.